Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 DOI:

Diabetes Spectrum - United States
doi 10.2337/ds18-er04
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Optimal Prandial Timing of Bolus Insulin in Diabetes Management: A Review

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

BeAM Value: An Indicator of the Need to Initiate and Intensify Prandial Therapy in Patients With Type 2 Diabetes Mellitus Receiving Basal Insulin

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2016English

Impact of Metformin Versus the Prandial Insulin Secretagogue, Repaglinide, on Fasting and Postprandial Glucose and Lipid Responses in Non-Obese Patients With Type 2 Diabetes

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2011English

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Metformin Reduces Post-Prandial Insulin Needs in Type I (Insulin-Dependent) Diabetic Patients: Assessment by the Artificial Pancreas

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1982English

Pdb74 - Ideglira Versus Iglarlixi for Patients With Inadequately Controlled Type 2 Diabetes on Basal Insulin: A Long-Term Cost-Effectiveness Analysis in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy